Latest Stock Market News
Valuations looking reasonable, but earnings growth remains a concern: Dipan MehtaUpdated at : 2025-02-19 11:20:02 Rate this item (1 Vote)Specifically, we do not have a stock list ready, like a shopping list per se. We are still observing what has happened in the quarter which has gone by. |
Dr. Reddy’s shares fall 6%, Aurobindo Pharma 10% as Trump signals 25% tariffs on pharma importsUpdated at : 2025-02-19 11:20:02 Rate this item (1 Vote)Dr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India s largest drugmaker, declined by 3.2% to Rs 1,647.35, becoming the top loser on the BSE Sensex and one of the top five decliners on the Nifty 50. |
Stocks to buy in 2025: UltraTech Cements, Glenmark Pharma among top 5 ideas that could give 20-30% returnsUpdated at : 2025-02-19 11:20:02 Rate this item (1 Vote)Top brokerage firms highlight investment opportunities in stocks for 2025, projecting 20-30% returns. Motilal Oswal recommends UltraTech Cements and Glenmark Pharma, while JPMorgan favors Persistent Systems. Citi is optimistic about Shriram Finance and gives a neutral rating to United Spirits with notable potential gains. These recommendations entail stocks across various promising sectors. |
BSE, NBCC Forgings among 5 stocks with long buildupUpdated at : 2025-02-19 11:20:02 Rate this item (1 Vote)
|
Death Crossovers: These 4 stocks signal further bearishness on Feb 19Updated at : 2025-02-19 10:20:02 Rate this item (1 Vote)These stocks 50-day SMA crossed below their 200-day SMAs on February 18. |
Stocks to buy today: Cipla, ONGC among top 9 trading ideas for 19 February 2025Updated at : 2025-02-19 10:20:02 Rate this item (1 Vote)The Indian market is expected to consolidate on Wednesday, influenced by muted global cues. The Nifty futures closed slightly negative, with significant options data suggesting a broader trading range between 22,500 to 23,500 zones. Various technical analysts have recommended stocks such as LTIMindTree, Cipla, NTPC, and Wipro for short-term trading with specified targets and stop losses. |
Piramal Pharma shares in focus after US FDA issues six observations for Mumbai facilityUpdated at : 2025-02-19 10:20:02 Rate this item (1 Vote)Piramal Pharma shares will be in focus after the US FDA s GMP inspection at its Turbhe facility from February 11-17, 2025, resulting in a Form 483 with six observations. The company confirmed that these relate to procedural improvements, not data integrity. Additionally, Piramal reported a 13% YoY revenue growth in Q3FY25, with a strong target price outlook. |
These 6 stocks showing RSI Trending Up on February 18Updated at : 2025-02-19 10:20:02 Rate this item (1 Vote)An uptrend signal occurs when the RSI value crosses above 50 from below. |
Tech heavyweights drag Sensex over 100 points lower; Nifty below 22,900Updated at : 2025-02-19 10:20:02 Rate this item (1 Vote)
|
I-Sec upgrades GlaxoSmithKline Pharma to Add, lowers target price to Rs 2,250Updated at : 2025-02-19 10:20:02 Rate this item (1 Vote)ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma s earnings are expected to see a CAGR of 15.3% over FY24-27. The company has an asset-light and cash-rich balance sheet, which could improve its return on equity and return on capital employed. |